http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2425004-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aecb5d203a63cdb920c41dbf7a44925e |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-241 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-417 |
| filingDate | 2011-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_480957558d18a1bac9cb33d2acf9e1a6 |
| publicationDate | 2013-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2425004-A2 |
| titleOfInvention | Combined pharmaceutical composition and its use to prepare a drug for the treatment of diseases or functional conditions of the gastrointestinal tract |
| abstract | Combined pharmaceutical composition and its use to prepare a medicine for the treatment of diseases or functional conditions of the gastrointestinal tract. The present invention provides a combined pharmaceutical composition that includes a) an activated-enhanced form of an antibody of an S-100 protein, b) an activated-enhanced form of an anti-histamine antibody, and c) an activated-enhanced form of a anti-TNF-alpha antibody. Various applications and variants are included. The present invention provides the use of a combined pharmaceutical composition that includes a) an activated-potentiated form of an anti-histamine antibody, b) an activated-enhanced form of an S-100 protein antibody and c) an activated-potentiated form of an anti-TNF-alpha antibody to prepare a medicament for the treatment of a disease or condition of functional etiology of the gastrointestinal tract. Various applications and variants are included. |
| priorityDate | 2010-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 399.